TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Don't Miss
Advertisement

At 9.33%, case fatality rate max in those aged over 70

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Naina Mishra

Advertisement

Tribune News Service

Advertisement

Chandigarh, April 10

Seventeen persons have already died due to Covid-19 in the city in just 10 days of this month. A majority of those who succumbed to the illness were aged above 70 years (six deaths) while five fell in the age group of 51 to 60 years.

Advertisement

At 9.33 per cent, the cases fatality rate is higher among patients aged above 70 in the city. In epidemiology, a case fatality rate is the proportion of deaths compared to the total number of people diagnosed with the disease.

As per the data presented by the UT Administration to a team of the Union Ministry of Health and Family Welfare, the age-wise case fatality rate of patients aged 41-50 years is 1.19 per cent, followed by 2.04 per cent (51-60 years), 3.14 per cent (61-70 years) and 9.33 percent (70 years and above).

Common comorbidities that aggravated the illness among patients were diabetes and hypertension. More than 47 per cent victims had diabetes and 49 per cent were already suffering from hypertension.

64% males among victims

It has been observed that the mortality rate is higher among males. Of the 377 deaths reported from the city till April 4, over 64 per cent were males.

Advertisement
Show comments
Advertisement